Ingenol: pharmacokinetic, mechanism of action and clinical applications
Ingenol, derived from Euphorbia peplus, shows promise in dermatology for its minimal systemic absorption and diverse therapeutic effects.
Dec 1，2023 API
Hydroxychloroquine: mechanisms of action, pharmacokinetics and safety
Hydroxychloroquine has diverse mechanisms of action, pharmacokinetics, and potential adverse effects in treating autoimmune diseases.
Dec 1，2023 API
5-Methyltetrahydrofolic acid: pharmacokinetics and physiological actions
5-Methyltetrahydrofolic acid is a crucial form of folate involved in absorption, distribution, metabolism, and excretion, regulating homocysteine levels.
Dec 1，2023 API
Zirconium n-butoxide: versatile applications and safety
Zirconium n-butoxide enables the synthesis of versatile nanoparticles, composite sols, and unique thio/oxothio clusters, but requires strict safety precautions.
Dec 1，2023 API
ABT-888: pharmacokinetic, mechanism of action and safety
ABT-888, a potent PARP inhibitor with favorable pharmacokinetics, shows promise in cancer therapy.
Dec 1，2023 API
Ethyl 4-oxocyclohexanecarboxylate: properties, applications and safety
Ethyl 4-oxocyclohexanecarboxylate has unique properties for industrial use but requires careful safety management.
Dec 1，2023 API
Epiandrosterone: physiological effects and applications
Epiandrosterone, a natural steroid hormone, influences androgen levels, cognition, mood, and metabolic pathways.
Dec 1，2023 APIAcute Toxicologic Evaluation at p-Anisidine
p-Anisidine produced conjunctival injection, chemosis, and colorless diseharge. Miosis was observed from 15 min-2 hrs. Ocular effects disappeared in 1 eye at 72 hrs.
Dec 1，2023 API
(S)-22-(Tert-butoxycarbonyl)-10,19,24-trioxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontane-1,41-dioic acid: properties and applications
(S)-22-(Tert-butoxycarbonyl)-10,19,24-trioxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontane-1,41-dioic acid is valued in biomedical and pharmaceutical research.
Dec 1，2023 API
Antimicrobial, cytotoxic, and antioxidant activities and physicochemical characteristics of chromium(III) complexes with
The results presented in this report may be useful for further studies evaluating the effects of the tested chromium(III) complexes on human body as antioxidants or dietary supplements substituting Cr
Dec 1，2023 API